Share on

Global Single-Cell Analysis Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Cells (Human Cells, Animal Cells and Microbial Cells), Products, Technique, Application and Region – Industry Forecast (2022 to 2027).

Published: January, 2022
ID: 2653
Pages: 182
Formats: report pdf report excel report power bi report ppt

Single-Cell Analysis Market Size (2022 to 2027)

As per our report, the global single-cell analysis market size is estimated to be worth USD 4.85 billion by 2027 and USD 2.26 billion in 2022, growing at a CAGR of 16.5% during the forecast period.

Single-Cell Analysis Market Share Insights:

  • Based on the application, the cancer research segment alone accounted for 28.5% of the global market share in 2021.
  • Based on the end-user, the academic and research laboratories segment had a share of 69.6% in the global market in 2021.
  • North America had 34.2% of the global market share in 2021.
  • The European region is anticipated to be worth USD 1.4 billion by 2027.
  • The market in the Asia-Pacific region is estimated to grow at a CAGR of 18.61% from 2022 to 2027.

In cellular biology, single-cell analysis consists of the study of genomics, proteomics, metabolomics, and so in at the single-cell level. Due to the vast differences between cells, both prokaryotes and eukaryotes analyzing single cells make it possible to unveil the mechanisms that could not be seen otherwise. Modern innovations such as Fluorescence-Activated Cell Sorting have increased the efficiency of cell sorting. Other technological advances are increasing our chances of sequencing the genome and transcriptome. The applications of studying the genome at a single-cell level include tracking the changes that occur in bacteria and exploring the genetic evolution of cancer. Additional research today has helped biologists learn more about gene expression profiles in individual cells.


The growing aging population, the high prevalence of infectious diseases, and the increasing preference towards precision medicine are propelling the single-cell analysis market growth.

As the health problems worldwide continue to rise, the need for research to develop better and more effective medicines also increases. Along with the technological advancements in single-cell analysis products, it is expected to drive the market forward.

Widening single-cell analysis applications in genomics, transcriptomics, proteomics, and epigenetic studies further boosts market growth. Similarly, big players are investing in R & D to evaluate single-cell analysis applications in stem cell transplant procedures to improve these processes' success rates. Furthermore, the advent of advanced devices that allow secure procedures for transcriptomics and proteomics causes the adoption of single-cell analysis techniques. Over the forecast period, government marketing schemes and measures like Health Japan 21 and Germany's Preventive Health Care Act are expected to fuel market growth. Factors such as the high prevalence of neurological disorders and the increase in disease incidence also drive market growth.


Factors significantly hindering the growth of the global single-cell analysis market are the high costs associated, restricted healthcare reimbursement policies, and concerns related to intellectual property rights. Moreover, growing competition for new entries into the market obstructs the single-cell analysis market growth during the forecast period.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Cell Type, Technique, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global single-cell analysis market has been segmented based on the cell type, technique, application, end-user, and region.

Single-Cell Analysis Market - By Cell Type:

  • Human
  • Animal
  • Microbial

Based on cell type, the class of human cells had the largest market share in the last few years and is projected to grow as fast as possible throughout the forecast period. It would be due to the rising prevalence of infectious diseases in the geriatric population and stem cell research funding.

Single-Cell Analysis Market - By Technique:

  • Flow Cytometry
  • Next-generation Sequencing
  • Polymerase Chain Reaction (PCR)
  • Microscopy
  • Mass Spectrometry
  • Other Techniques

The flow cytometry segment is expected to lead the market during the forecast period based on the technique. It is due to the broad usage of flow cytometry in identifying and measuring the physical and chemical characteristics of the population of cells or particles.

Simultaneously, the NGS segment is anticipated to have the highest growth rate during the review period because of the increasing applications among the products in drug discovery for cancer and other constant and continuous diseases propelling the single-cell analysis growth during the analysis period.

Single-Cell Analysis Market - By Application:

  • Research Applications
    • Cancer Research
    • Immunology Research
    • Neurology Research
    • Stem Cell Research
    • Other Research Applications
  • Medical Application
  • Non-invasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell Detection

Based on the application, the research applications segment held the larger market share during the historical period. Due to the availability of increased funds, this class is further expected to maintain its dominance during the forecast period.

Single-Cell Analysis Market - By End User:

  • Academic and Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Hospital and Diagnostic Laboratories

Based on the end-user, the Hospitals and diagnostic laboratories segment is expected to dominate during the forecast period due to continuous efforts to cover the gap in implementing OMICs technology from the research laboratories to clinical settings. In addition, these hospitals provide high-quality diagnostic care and a safe environment for patients.

Single-Cell Analysis Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the global market was dominated by the North American single-cell analysis market in 2021, with the region accounting for 37% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. North America will dominate the global single-cell analysis market over the forecast period. Existing application of cell analysis in drug discovery, the growing elderly people population, and continuous development in the field of single-cell analysis fuels the market growth over the forecast period. U.S. is dominating the market due to developments in modern therapeutics like IVF and parenteral screening driving the U.S. market. The U.S. follows Canada due to the standard increase of chronic diseases propelling growth.

The single-cell analysis market in Europe is expected to lead the second-largest market in the single-cell analysis over the analysis period after North America due to increasing consumer awareness regarding advanced technologies, growing research, and development activities. The U.K. is leading the market due to increasing expenditure is fuelling the growth. However, Germany is expected to have speedy growth after the U.K. due to the increasing occurrence rate of infectious diseases.

The single-cell analysis market in APAC is expected to overgrow in the coming years, as evidenced by the high CAGR value for the region. China is dominating the cell analysis market and is expected to continue its growth due to the increasing elder people population. On the other hand, India is estimated to have noticeable and considerable growth over the analysis period due to increasing biotechnology and pharmaceutical companies.

During the forecast period, the Latin American single-cell analysis market is anticipated to grow at a steady CAGR. The growth of the regional market is driven by the growing number of proteins produced and the development of cell lines. Brazil is expected to have the largest share of the market due to growing healthcare expenditure and an increasing patient population.

The single-cell analysis market in MEA is considered to have a slight inclination in the growth rate due to the development of advanced therapies for cancer treatment.


Some of the prominent companies leading the global single-cell analysis market profiled in the report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.


  • In July 2020, 10X Genomics launched its chromium single-cell immunity profiling V2 product. This new product enlarges the initial version's abilities, assisting fundamental breakthroughs in immunology, oncology, autoimmunity, inflammation, and infectious diseases. In addition, the V2 product offers a thorough approach to concurrently testing the cellular heterogeneity of the immune system T and B cells.
  • In April 2020, Bio-Rad Laboratories announced that it had obtained Celsee Inc., which provides a scalable, practical, and efficient approach to identifying single cells. In addition, the system can layer thousands to millions of cells for genomic and proteomic applications.
  • In June 2019, Beckman Coulter Life Sciences made a public statement regarding the obtainment of Cytobank, a single-cell data analysis. The Cytobank platform boosts research manufacturing by allowing structured high-dimensional data analysis and collaboration across the globe.

Please wait. . . . Your request is being processed


How much was the global single-cell analysis market worth in 2021?

The global single-cell analysis market was valued at USD 1.94 billion in 2021.

Which segment by cell type led the single-cell analysis market in 2021?

Based on the cell type, the human cell segment accounted for the leading share of the market in 2021.

Which region is anticipated to grow fastest in the global single-cell analysis market?

Geographically, the Asia-Pacific region is predicted to grow the fastest in the global market during the forecast period.

Who are the leading players in the single-cell analysis market?

Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience are the notable players in the market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample